<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Mon, 13 Apr 2026 20:08:27 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/microfluidiccomponents/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Microfluidic Components Market worth $6.1 billion – Regenerative Medicine an Alternative to Organ Transplantation]]></title><description><![CDATA[The major factors driving the growth of this market are the rising demand for point-of-care testing, technological advancements, increasing focus on data precision and accuracy, fast return on investments,]]></description><link>http://direct.ecency.com/microfluidiccomponents/@healthcarer/microfluidic-components-market-worth-usd6-1-billion-regenerative-medicine-an-alternative-to-organ-transplantation</link><guid isPermaLink="true">http://direct.ecency.com/microfluidiccomponents/@healthcarer/microfluidic-components-market-worth-usd6-1-billion-regenerative-medicine-an-alternative-to-organ-transplantation</guid><category><![CDATA[microfluidiccomponents]]></category><dc:creator><![CDATA[healthcarer]]></dc:creator><pubDate>Wed, 17 Feb 2021 09:06:21 GMT</pubDate></item></channel></rss>